Dynamic angiothermography

Last updated

Dynamic angiothermography (DATG) is a technique for the diagnosis of breast cancer. This technique, though springing from the previous conception of thermography, is based on a completely different principle. DATG records the temperature variations linked to the vascular changes in the breast due to angiogenesis. The presence, change, and growth of tumors and lesions in breast tissue change the vascular network in the breast. Consequently, through measuring the vascular structure over time, DATG effectively monitors the change in breast tissue due to tumors and lesions. It is currently used in combination with other techniques for diagnosis of breast cancer. This diagnostic method is a low-cost one compared with other techniques.

Contents

Angiothermography is not a test that substitutes for other tests, but stands in relation to them as a technique that gives additional information to clarify the clinical picture and improve the quality of diagnosis.

History

In the early 1970s, studies of Professor J. Tricoire in France focused on the application of contact thermography for the screening of breast cancer using plates with liquid crystals. [1] [2] The principle, on which the methodology developed by Tricoire was based, was to record and map the heat generated by possibly emergent tumors. These studies had a unique debut, since the examination was absolutely non-invasive (no radiation or contrast agents are required). The test is performed by putting the thermal detection screen in contact with the breast, allowing time for image formation, and analyzing the resultant image. While some detection of tumors and lesions was demonstrated, the technique also had a propensity for substantial false positives (non-existent cancer diagnosed). [3]

During the time at which contact thermography screening was being practiced, more detailed studies on the change in the breast due to the presence of tumors and lesions were being performed. The connection between breast tumors and vascularization was highlighted and studied in detail by Judah Folkman in his research on angiogenesis which began in 1965. These studies, the more complete description of this process, and the models emergent from this work, earned Folkman the Wolf Prize in Medicine in 1992.

Dynamic angiothermography utilizes thermal imaging, but with important differences from the older kind of thermography, which impact detection performance. First, the probes are much improved over the previous liquid crystal plates; they include better spatial resolution, contrastive performance, and the image is formed more quickly. The more significant difference [4] lies in identifying the thermal changes due to changes in vascular network to support the growth of the tumor or lesion. Instead of just recording the change in heat generated by the tumor, the image is now able to identify changes due to the vascularization of the mammary gland. In order for a tumor to originate, develop and grow, an enhanced blood supply is necessary (angiogenesis theory). The more detailed map of the vascular network contains information pointing to the location where the breast has changed to accommodate the tumor. More importantly, the ability to visualize tumors in a precancerous state enables prompt and strategic removal, which of course removes the cause of the tumor. [5]

The general idea emerging from several clinical studies is that every woman has their own blood pattern image, which is like a fingerprint and, in healthy women, can remain unchanged over time. [6] Changes in this "fingerprint" are evidence of a suspected tumoral or pre-tumoral activity.

Description

The current state of the equipment, by which this examination is done, consists of two parts, and can be combined into a highly mobile footprint. The first component is the thermographic sensor to be placed on the breast. The second is a connection to a computer that records the acquired images. The sensor records the distribution of blood at temperatures between 30 °C and 35 °C. When the sensor is leaning on the breast, the heat, produced by vascularization, induces an image due to the change of the liquid crystal state that passes from solid (black coloured) to liquid. While in the previous contact thermography the doctor studied the colour distribution, in the new methodology (dynamic angiothermography) the image is inspected for information conveyed about local blood distribution. In a healthy breast, the pattern formed by normal vascularization looks like a pointed image in the direction of the nipple. In the case of a tumor, or even of a precancerous lesion, the pattern appears to have rounded shapes which converge from different areas of the breast to feed the tumor. The images can be interpreted visually by the doctor, and/or evaluated with the aid of digital image enhancement tools. Future possibilities extend to more automated detection using computer-aided inspection. The standard procedure is that the doctor looks examines the patient clinically (with palpation) and then acquires two projections of the right breast (side and front) and two of the left (side and front). Digital photos are also acquired and these results are compared with other pictures previously acquired. In the case of evident superficial veins, the breast must be cooled with a current of cold air.

Comparison with other techniques

Comparative diagnostic exams of reference for the cancer of the breast are mammography (the "gold" standard), ultrasounds, and for 3D imaging, nuclear magnetic resonance or recently developed approaches to CT of the breast.

DATG is not a test that directly substitutes for other tests, but stands in relation to them as a technique that provides a detailed and non-invasive look at the changes in blood flow in the breast. [7] As such, it has been most successfully employed in combination with other tests to improve the quality of the diagnosis. Further, it may be the most non-invasive technique possible for performing early screening.

Mammography measures the differences of the tissue density inside the breast with substantial spatial resolution but requires at least a low dose of radiation. In many cases the tumors or lesions are directly imaged with respect to size and shape. Image interpretation for mammograms is mature and can be effective. However, there are concerns that the higher density of breast tissue in patients younger than 40–45 years of age degrades the diagnostic information obtained in this technique. Some studies have shown that mammography is less effective before age 50. [8] It is also difficult to see precancerous lesions with mammography, which have not emerged into localized density changes imaged by the low dose of radiation.

Ultrasound inspections can be applied to women of any age and do not involve the use of radiation. Further, ultrasound techniques can measure the size of the tumor and are able to differentiate solids from liquids in breast tissue. However, due to the general equality in acoustic impedance for many types of structures in the breast, ultrasound imaging detects many abnormalities or potential sites that are false positives, limiting its usefulness. Doppler ultrasound can provide some information on blood flow in the breast, but this is a substantial variation on regular ultrasound inspections. Overall, ultrasound techniques are best employed to evaluate a lump discovered by some other means and/or to investigate a specific site identified by mammography.

Nuclear magnetic resonance (NMR) scanning, as DATG does, can map the blood flow distribution in the breast, and provides information for patients of all ages. However, this technique is most effective with the use of a contrast agent that is mildly invasive, with some risk of a negative reaction. Compared to DATG, these scans require substantial facilities and the scanning and interpretation is considerably more expensive.

Breast CT scanning employs penetrating radiation and so includes some x-ray dose delivered to the patient. [9] Unlike in mammography, the breast is not flattened or manipulated to equalize the contrast. Instead, gravity is used and the breast hangs down into the source detector envelope. For the same dose delivered in mammography, breast CT produces 3D volumetric images of tumors and lesions that can show the connection to the vascular network. Further, these images can be evaluated with the same image analysis tools resident for general CT imaging. As in the case of NMR, the hardware footprint of this type of scanning is more substantial than DATG.

Dynamic angiothermography (DATG) is a technique that does not require ionizing radiation or toxic contrast agents, can be used on patients of all ages, has good specificity and is able to diagnose even precancerous lesions [5] while it is not able to measure the size of a tumor or lesion.

Advantages and disadvantages

DATG is able to detect changes in blood flow that are indicative of breast cancer, may be used for younger patients, is non-invasive (no need for radiation or contrast agent, no need for compression of the breast) and is lower-cost than alternatives requiring minimal facilities. This technology, performed quickly (5–6 minutes for visit) and very precise, is useful for screening and is also able to detect precancerous lesions. [5] Studies have been conducted that have shown how it is possible, by means of this methodology, to diagnose invasive ductal carcinoma and infiltrating lobular carcinoma with the same accuracy. [10] DATG can be strategic for young patients, or patients with dense breasts where the contrastive performance of mammography is challenged. [11] Another application of DATG is the monitoring of at-risk patients with increased changes of breast cancer who take hormone replacement therapy (sometimes taken to reduce menopause symptoms) and participate in in-vitro fertilization.

By contrast DATG is not able to determine the size of the tumor. Rather, the diagnostic information from DATG indicates the presence of a suspicious lesion and points to the area where to look for it. In fact, the intensity and the size of the features in the image acquired by DATG are not correlated to the shape and size of the tumor but to its underlying biological activity (see angiogenesis described above). Lastly, the interpretation of DATG images can be done either by a radiologist, surgeon, oncologist, gynecologist or simply by a medical professional after explicit training to evaluate the DATG images.

Related Research Articles

<span class="mw-page-title-main">Medical ultrasound</span> Diagnostic and therapeutic technique

Medical ultrasound includes diagnostic techniques using ultrasound, as well as therapeutic applications of ultrasound. In diagnosis, it is used to create an image of internal body structures such as tendons, muscles, joints, blood vessels, and internal organs, to measure some characteristics or to generate an informative audible sound. The usage of ultrasound to produce visual images for medicine is called medical ultrasonography or simply sonography, or echography. The practice of examining pregnant women using ultrasound is called obstetric ultrasonography, and was an early development of clinical ultrasonography. The machine used is called an ultrasound machine, a sonograph or an echograph. The visual image formed using this technique is called an ultrasonogram, a sonogram or an echogram.

<span class="mw-page-title-main">Cytopathology</span> A branch of pathology that studies and diagnoses diseases on the cellular level

Cytopathology is a branch of pathology that studies and diagnoses diseases on the cellular level. The discipline was founded by George Nicolas Papanicolaou in 1928. Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathology is frequently, less precisely, called "cytology", which means "the study of cells".

<span class="mw-page-title-main">Mammography</span> Process of using low-energy X-rays to examine the human breast for diagnosis and screening

Mammography is the process of using low-energy X-rays to examine the human breast for diagnosis and screening. The goal of mammography is the early detection of breast cancer, typically through detection of characteristic masses or microcalcifications.

<span class="mw-page-title-main">Biopsy</span> Medical test involving extraction of sample cells or tissues for examination

A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist. The process involves extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is then fixed, dehydrated, embedded, sectioned, stained and mounted before it is generally examined under a microscope by a pathologist; it may also be analyzed chemically. When an entire lump or suspicious area is removed, the procedure is called an excisional biopsy. An incisional biopsy or core biopsy samples a portion of the abnormal tissue without attempting to remove the entire lesion or tumor. When a sample of tissue or fluid is removed with a needle in such a way that cells are removed without preserving the histological architecture of the tissue cells, the procedure is called a needle aspiration biopsy. Biopsies are most commonly performed for insight into possible cancerous or inflammatory conditions.

Technetium (<sup>99m</sup>Tc) sestamibi Pharmaceutical drug

Technetium (99mTc) sestamibi (INN) is a pharmaceutical agent used in nuclear medicine imaging. The drug is a coordination complex consisting of the radioisotope technetium-99m bound to six (sesta=6) methoxyisobutylisonitrile (MIBI) ligands. The anion is not defined. The generic drug became available late September 2008. A scan of a patient using MIBI is commonly known as a "MIBI scan".

Computed tomography laser mammography (CTLM) is the trademark of Imaging Diagnostic Systems, Inc. for its optical tomographic technique for female breast imaging.

<span class="mw-page-title-main">Phyllodes tumor</span> Medical condition

Phyllodes tumors, are a rare type of biphasic fibroepithelial mass that form from the periductal stromal and epithelial cells of the breast. They account for less than 1% of all breast neoplasms. They were previously termed cystosarcoma phyllodes, coined by Johannes Müller in 1838, before being renamed to phyllodes tumor by the World Health Organization in 2003. Phullon, which means 'leaf' in Greek, describes the unique papillary projections characteristic of phyllodes tumors on histology. Diagnosis is made via a core-needle biopsy and treatment is typically surgical resection with wide margins (>1 cm), due to their propensity to recur.

<span class="mw-page-title-main">Breast MRI</span> Form of breast imaging

One alternative to mammography, breast MRI or contrast-enhanced magnetic resonance imaging (MRI), has shown substantial progress in the detection of breast cancer.

<span class="mw-page-title-main">Ductal carcinoma in situ</span> Medical condition

Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma, is a pre-cancerous or non-invasive cancerous lesion of the breast. DCIS is classified as Stage 0. It rarely produces symptoms or a breast lump one can feel, typically being detected through screening mammography. It has been diagnosed in a significant percentage of men.

<span class="mw-page-title-main">Computer-aided diagnosis</span> Type of diagnosis assisted by computers

Computer-aided detection (CADe), also called computer-aided diagnosis (CADx), are systems that assist doctors in the interpretation of medical images. Imaging techniques in X-ray, MRI, Endoscopy, and ultrasound diagnostics yield a great deal of information that the radiologist or other medical professional has to analyze and evaluate comprehensively in a short time. CAD systems process digital images or videos for typical appearances and to highlight conspicuous sections, such as possible diseases, in order to offer input to support a decision taken by the professional.

Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy and systemic treatment. Local therapy is most efficacious in early stage breast cancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific phenotypes.

<span class="mw-page-title-main">Breast cancer screening</span> Medical screening of asymptomatic, healthy women for breast cancer

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis. The assumption is that early detection will improve outcomes. A number of screening tests have been employed, including clinical and self breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

<span class="mw-page-title-main">Molecular breast imaging</span>

Molecular breast imaging (MBI), also known as scintimammography, is a type of breast imaging test that is used to detect cancer cells in breast tissue of individuals who have had abnormal mammograms, especially for those who have dense breast tissue, post-operative scar tissue or breast implants.

<span class="mw-page-title-main">Breast biopsy</span> Surgical procedure

A breast biopsy is usually done after a suspicious lesion is discovered on either mammography or ultrasound to get tissue for pathological diagnosis. Several methods for a breast biopsy now exist. The most appropriate method of biopsy for a patient depends upon a variety of factors, including the size, location, appearance and characteristics of the abnormality. The different types of breast biopsies include fine-needle aspiration (FNA), vacuum-assisted biopsy, core needle biopsy, and surgical excision biopsy. Breast biopsies can be done utilizing ultrasound, MRI or a stereotactic biopsy imaging guidance. Vacuum assisted biopsies are typically done using stereotactic techniques when the suspicious lesion can only be seen on mammography. On average, 5–10 biopsies of a suspicious breast lesion will lead to the diagnosis of one case of breast cancer. Needle biopsies have largely replaced open surgical biopsies in the initial assessment of imaging as well as palpable abnormalities in the breast.

<span class="mw-page-title-main">Positron emission mammography</span> Imaging procedure used to detect breast cancer

Positron emission mammography (PEM) is a nuclear medicine imaging modality used to detect or characterise breast cancer. Mammography typically refers to x-ray imaging of the breast, while PEM uses an injected positron emitting isotope and a dedicated scanner to locate breast tumors. Scintimammography is another nuclear medicine breast imaging technique, however it is performed using a gamma camera. Breasts can be imaged on standard whole-body PET scanners, however dedicated PEM scanners offer advantages including improved resolution.

Automated whole-breast ultrasound (AWBU) is a medical imaging technique used in radiology to obtain volumetric ultrasound data of the entire breast.

Interventional oncology is a subspecialty field of interventional radiology that deals with the diagnosis and treatment of cancer and cancer-related problems using targeted minimally invasive procedures performed under image guidance. Interventional oncology has developed to a separate pillar of modern oncology and it employs X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide miniaturized instruments to allow targeted and precise treatment of solid tumours located in various organs of the human body, including but not limited to the liver, kidneys, lungs, and bones. Interventional oncology treatments are routinely carried out by interventional radiologists in appropriate settings and facilities.

<span class="mw-page-title-main">Breast imaging</span>

In medicine, breast imaging is a sub-speciality of diagnostic radiology that involves imaging of the breasts for screening or diagnostic purposes. There are various methods of breast imaging using a variety of technologies as described in detail below. Traditional screening and diagnostic mammography uses x-ray technology and has been the mainstay of breast imaging for many decades. Breast tomosynthesis is a relatively new digital x-ray mammography technique that produces multiple image slices of the breast similar to, but distinct from, computed tomography (CT). Xeromammography and galactography are somewhat outdated technologies that also use x-ray technology and are now used infrequently in the detection of breast cancer. Breast ultrasound is another technology employed in diagnosis and screening that can help differentiate between fluid filled and solid lesions, an important factor to determine if a lesion may be cancerous. Breast MRI is a technology typically reserved for high-risk patients and patients recently diagnosed with breast cancer. Lastly, scintimammography is used in a subgroup of patients who have abnormal mammograms or whose screening is not reliable on the basis of using traditional mammography or ultrasound.

Ultrasonography of liver tumors involves two stages: detection and characterization.

A specific branch of contrast-enhanced ultrasound, acoustic angiography is a minimally invasive and non-ionizing medical imaging technique used to visualize vasculature. Acoustic angiography was first developed by the Dayton Laboratory at North Carolina State University and provides a safe, portable, and inexpensive alternative to the most common methods of angiography such as Magnetic Resonance Angiography and Computed Tomography Angiography. Although ultrasound does not traditionally exhibit the high resolution of MRI or CT, high-frequency ultrasound (HFU) achieves relatively high resolution by sacrificing some penetration depth. HFU typically uses waves between 20 and 100 MHz and achieves resolution of 16-80μm at depths of 3-12mm. Although HFU has exhibited adequate resolution to monitor things like tumor growth in the skin layers, on its own it lacks the depth and contrast necessary for imaging blood vessels. Acoustic angiography overcomes the weaknesses of HFU by combining contrast-enhanced ultrasound with the use of a dual-element ultrasound transducer to achieve high resolution visualization of blood vessels at relatively deep penetration levels.

References

  1. ↑ Rouvillois C, Tricoire J, Mariel L, Portier F (November 1973). "[Thermography using contact plates in the diagnosis of breast cancers]". Chirurgie; Mémoires de l'Académie de Chirurgie (in French). 99 (11): 866–72. PMID   4792563.
  2. ↑ Tricoire J (1975). "[Study of breast cancer by means of liquid crystals thermography]". Journal de Gynécologie, Obstétrique et Biologie de la Reproduction (in French). 4 SUPPL 2: 123–30. PMID   1194631.
  3. ↑ Dodd, Gerald D. (June 1977). "Present status of thermography, ultrasound and mammography in breast cancer detection". Cancer. 39 (6 Suppl): 2796–805. doi: 10.1002/1097-0142(197706)39:6<2796::AID-CNCR2820390667>3.0.CO;2-0 . PMID   872067.
  4. ↑ Montruccoli GC, Montruccoli Salmi D, Casali F (January–March 2004). "A new type of breast contact thermography plate: a preliminary and qualitative investigation of its potentiality on phantoms". Physica Medica. 20 (1): 27–31.
  5. 1 2 3 Longatto Filho A, Costa SM, Milanezi F, et al. (November 2007). "Immunohistochemical expression of VEGF-A and its ligands in non-neoplastic lesions of the breast sampling-assisted by dynamic angiothermography". Oncology Reports. 18 (5): 1201–6. doi: 10.3892/or.18.5.1201 . PMID   17914573.
  6. ↑ Isard HJ, Becker W, Shilo R, Ostrum BJ (August 1972). "Breast thermography after four years and 10000 studies". The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine. 115 (4): 811–21. doi: 10.2214/ajr.115.4.811 . PMID   5054275.
  7. ↑ Kennedy DA, Lee T, Seely D (March 2009). "A comparative review of thermography as a breast cancer screening technique". Integrative Cancer Therapies. 8 (1): 9–16. doi: 10.1177/1534735408326171 . PMID   19223370.
  8. ↑ Berrington de González A, Reeves G (September 2005). "Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits". British Journal of Cancer. 93 (5): 590–6. doi:10.1038/sj.bjc.6602683. PMC   2361593 . PMID   16136033.
  9. ↑ Boone JM, Kwan AL, Yang K, Burkett GW, Lindfors KK, Nelson TR (April 2006). "Computed tomography for imaging the breast". Journal of Mammary Gland Biology and Neoplasia. 11 (2): 103–11. doi:10.1007/s10911-006-9017-1. PMID   17053979. S2CID   25758608.
  10. ↑ Naccarato AG, Viacava P, Bocci G, et al. (December 2003). "Definition of the microvascular pattern of the normal human adult mammary gland". Journal of Anatomy. 203 (6): 599–603. doi:10.1046/j.1469-7580.2003.00244.x. PMC   1571199 . PMID   14686695.
  11. ↑ Choi BB, Kim SH, Park CS, Cha ES, Lee AW (February 2011). "Radiologic findings of lobular carcinoma in situ: mammography and ultrasonography". Journal of Clinical Ultrasound. 39 (2): 59–63. doi:10.1002/jcu.20772. PMID   21213330. S2CID   22540643.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.